Changes in blood coagulation during and following cardiopulmonary bypass: Lack of correlation with clinical bleeding

American Journal of Clinical Pathology

Volumn 106, Issue 1, 1996, Pages 87-99

  Gelb, Arnold B ^a   Roth, Robert I ^a   Levin, Jack ^a,f   London, Martin J ^a,b   Noall, Rhoda A ^a,c   Hauck, Walter W ^a,d   Cloutier, Michele ^a   Verrier, Edward ^a,e   Mangano, Dennis T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c IRTF Hilo   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Blood coagulation, abnormalities of; Cardiopulmonary bypass (CPB); Cardiopulmonary bypass graft CABG ; Coagulation factors, levels of; Fresh frozen plasma; Hemostasis; Platelet transfusions

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ARTICLE; BLEEDING; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MALE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION;

EID: 0030006986     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/106.1.87     Document Type: Article

References (82)

1. Bachmann F, McKenna R, Cole ER, Najafi H. The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. J Thorac Cardiovasc Surg 1975;70:76-85.
2. McKenna R, Bachmann F, Whittaker B, et al. The hemostatic mechanism after open-heart surgery. II. Frequency of abnormal platelet functions during and after extracorporeal circulation. J Thorac Cardiovasc Surg 1975;70:298-308.
3. Marengo-Rowe AJ, Lambert CJ, Leveson JE, et al. The evaluation of hemorrhage in cardiac patients who have undergone extracorporeal circulation. Transfusion 1979;19:426-433.
4. Harker LA, Malpass TW, Branson HE, et al. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective alpha-granule release. Blood 1980;56:824-834.
5. Milam JD, Austin SF, Martin RF, et al. Alteration of coagulation and selected clinical chemistry parameters in patients undergoing open heart surgery without transfusions. Am J Clin Pathol 1981;76:155-162.
6. Mammen EF, Koets MH, Washington BC, et al. Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost 1985;11:281-292.
7. Addonizio VP. Platelet function in cardiopulmonary bypass and artificial organs. Hematol Oncol Clin North Am 1990;4:145-155.
8. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990;76:1680-1697.
9. Teufelsbauer H, Proidl S, Havel M, Vukovich T. Early activation of hemostasis during cardiopulmonary bypass: Evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost 1992; 68:250-252.
10. Edmunds LJ. Blood-surface interactions during cardiopulmonary bypass. J Card Surg 1993;8:404-410.
11. Kestin AS, Valeri CR, Khuri SF, et al. The platelet function defect of cardiopulmonary bypass. Blood 1993;82:107-117.
12. Dodd RY. The risk of transfusion-transmitted infection [Editorial]. N Engl J Med 1992;327:419-421.
13. Pineda AA, Brzica SM Jr., Taswell HF. Hemolytic transfusion reaction. Recent experience in a large blood bank. Mayo Clin Proc 1978;53:378-390.
14. Honig CL, Bove JR. Transfusion-associated fatalities: Review of Bureau of Biologics reports 1976-1978. Transfusion 1980;20: 653-661.
15. Latson TW, Kickler TS, Baumgartner WA. Pulmonary hypertension and noncardiogenic pulmonary edema following cardiopulmonary bypass associated with an antigranulocyte antibody. Anesthesiology 1986;64:106-111.
16. Morrow JF, Braine HG, Kickler TS, et al. Septic reactions to platelet transfusions. A persistent problem. JAMA 1991;266:555-558.
17. Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med 1994;118:371-379.
18. Sazama K. Bacteria in blood for transfusion. A review. Arch Pathol Lab Med 1994;118:350-365.
19. Gralnick HR, Fischer RD. The hemostatic response to open-heart operations. J Thorac Cardiovasc Surg 1971;61:909-915.
20. Simon TL, Akl BF, Murphy W. Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery. Ann Thorac-Surg 1984;37:359-364.
21. Torosian M, Michelson EL, Morganroth J, MacVaugh H III. Aspirin- and coumadin-related bleeding after coronary-artery bypass graft surgery. Ann Intern Med 1978;89:325-328.
22. Cowan JF, Khan MB, Vargo J, Joist JH. An improved method for evaluation of blood coagulation in heparinized blood. Am J Clin Pathol 1981;75:60-64.
23. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haemat 1957;17:237-246.
24. Rush B, Ellis H. The treatment of patients with factor V deficiency. Thromb Diath Haemorrh 1965;14:74-82.
25. Hall CA, Rapaport SI, Ames SB, et al. A clinical and family study of hereditary proconvertin (factor VII) deficiency. Am J Med 1964;37:172-181.
26. Webster WP, Roberts HR, Penick GD. Hemostasis in factor V deficiency. Am J Med Sci 1964;248:194-202.
27. Marder VJ, Shulman NR. Clinical aspects of congenital factor VII deficiency. Am J Med 1964;37:182-194.
28. Seligsohn U, Shani M, Ramot B, et al. Dubin-Johnson syndrome in Israel. II. Association with factor-VII deficiency. Q J Med 1970;39:569-584.
29. Lee WH Jr, Krumhaar D, Fonkalsrud EW, et al. Denaturation of plasma proteins as a cause of morbidity and death after intracardiac operations. Surgery 1961;50:29-39.
30. Bachmann F, McKenna R, Whitaker B. Abnormale Thrombozy-tenfunktion mach Herzchirurgie mit extrakorporaler Zirkulation. Schweiz Med Wochenschr 1974;104:1374-1375.
31. Moriau M, Masure R, Hurlet A, et al. Haemostasis disorders in open heart surgery with extracorporeal circulation. Importance of the platelet function and the heparin neutralization. Vox Sang 1977;32:41-51.
32. Weiland AP, Walker WE. Physiologic principles and clinical sequelae of cardiopulmonary bypass [published erratum appears in Heart Lung 1986;15:465]. Heart Lung 1986;15:34-39.
33. Ramsey G, Arvan DA, Stewart S, Blumberg N. Do preoperative laboratory tests predict blood transfusion needs in cardiac operations? J Thorac Cardiovasc Surg 1983;85:564-569.
34. Lambert CJ, Marengo-Rowe AJ, Leveson J, et al. The tri-F titer: A rapid test for estimation of plasma fibrinogen and detection of fibrinolysis, fibrin(ogen) split products, and heparin. Ann Thorac Surg 1974;18:357-363.
35. Lambert CJ, Marengo-Rowe AJ, Leveson JE, et al. The treatment of postperfusion bleeding using epsilon-aminocaproic acid, cryoprecipitate, fresh-frozen plasma, and protamine sulfate. Ann Thorac Surg 1979;28:440-444.
36. Miller RD, Robbins TO, Tong MJ, Barton SL. Coagulation defects associated with massive blood transfusions. Ann Surg 1971;174: 794-801.
37. Counts RB, Haisch C, Simon TL, et al. Hemostasis in massively transfused trauma patients. Ann Surg 1979;190:91-99.
38. Mannucci PM, Federici AB, Sirchia G. Hemostasis testing during massive blood replacement. A study of 172 cases. Vox Sang 1982;42:113-123.
39. Soff GA, Levin J. Familial multiple coagulation factor deficiencies. I. Review of the literature: Differentiation of single hereditary disorders associated with multiple factor deficiencies from coincidental concurrence of single factor deficiency states. Semin Thromb Hemost 1981;7:112-148.
40. Soff GA, Levin J, Bell WR. Familial multiple coagulation factor deficiencies. II. Combined factor VIII, IX, and XI deficiency and combined factor IX and XI deficiency: Two previously uncharacterized familial multiple factor deficiency syndromes. Semin Thromb Hemost 1981;7:149-169.
41. Mullertz S, Storm O. Anticoagulant therapy with dicumarol maintained during major surgery. Circulation 1954;10:213-220.
42. Storm O, Hansen AT. Mitral commissurotomy performed during anticoagulation prophylaxis with dicumarol. Circulation 1955;12:981-985.
43. Gormsen J, Andersen A, Gammelgaard A. Prostatectomy during anticoagulant therapy. Acta Chir Scand 1961;120:380-387.
44. Skinner DB, Salzman EW. Anticoagulant prophylaxis in surgical patients. Surg Gynecol Obstet 1967;125:741-746.
45. Pritchard JA, Brekken AL. Clinical and laboratory studies on severe abruptio placentae. Am J Obstet Gynecol 1967;97:681-700.
46. Umlas J. Fibrinolysis and disseminated intravascular coagulation in open heart surgery. Transfusion 1976;16:460-463.
47. Lambert CJ, Geisler GF. Routine administration of platelet concentrates [Letter]. Ann Thorac Surg 1985;39:293-294.
48. Holloway DS, Summaria L, Sandesara J, et al. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost 1988;59:62-67.
49. Khuri SF, Wolfe JA, Josa M, et al. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg 1992;104:94-107.
50. Spiess BD. Cardiac anesthesia risk management. Hemorrhage, coagulation, and transfusion: A risk-benefit analysis. J Cardiothorac Vasc Anesth 1994;8:19-22.
51. Boldt J, Knothe C, Zickmann B, et al. Platelet function in cardiac surgery: Influence of temperature and aprotinin. Ann Thorac Surg 1993;55:652-658.
52. Murkin JM, Lux J, Shannon NA, et al. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. J Thorac Cardiovasc Surg 1994;107:554-561.
53. Tanaka K, Takao M, Yada I, et al. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothorac Anesth 1989;3:181-188.
54. Boyd AD, Engelman RM, Beaudet RL, Lackner H. Disseminated intravascular coagulation following extracorporeal circulation. J Thorac Cardiovasc Surg 1972;64:685-693.
55. Bayer WL, Coenen WM, Jenkins DC, Zucker ML. The use of blood and blood components in 1,769 patients undergoing open-heart surgery. Ann Thorac Surg 1980;29:117-122.
56. Verkkala K., Jarvinen A, Virtanen K, et al. Indications for and risks in reoperation for coronary artery disease. Scand J Thorac Cardiovasc Surg 1990;24:1-6.
57. National Institutes of Health Consensus Conference. Fresh frozen plasma: Indications and risks. Transfus Med Rev 1987;1:201-204.
58. Diehl JT, Lester JL III, Cosgrove DM. Clinical comparison of hetastarch and albumin in postoperative cardiac patients. Ann Thorac Surg 1982;34:674-679.
59. Diehl JT. Hydroxyethyl starch in CABG [Letter]. Ann Thorac Surg 1985;39:97-98.
60. Belcher P. Use of HES in cardiac surgery [Letter]. Ann Thorac Surg 1985;40:416.
61. London MJ, Ho JS, Triedman JK, et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 1989;97:785-797.
62. London MJ, Franks M, Verrier ED, et al. The safety and efficacy often percent pentastarch as a cardiopulmonary bypass priming solution: A randomized clinical trial. J Thorac Cardiovasc Surg 1992;104:284-296.
63. Goodnough LT, Johnston MF, Ramsey G, et al. Guidelines for transfusion support in patients undergoing coronary artery bypass grafting. Transfusion Practices Committee of the American Association of Blood Banks. Ann Thorac Surg 1990;50:675-683.
64. Goodnough LT, Johnston MF, Toy PT. The variability of transfusion practice in coronary artery bypass surgery. Transfusion Medicine Academic Award Group. JAMA 1991;265:86-90.
65. Lackritz EM, Satten GA, Aberle-Grasse J, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995;333:1721-1725.
66. Goldman M, Blajchman MA. Blood product-associated bacterial sepsis. Transfus Med Rev 1991;5:73-83.
67. Ciavarella D. Sepsis after platelet transfusions [Letter; comment]. JAMA 1992;267:1206.
68. Blajchman MA. Transfusion-associated bacterial sepsis: The phoenix rises yet again [Editorial]. Transfusion 1994;34:940-942.
69. Blood Components: Preparation, Storage and Shipment. In: Walker RH, Branch DR, Dzik WH, Judd WJ, eds. Technical Manual. Bethesda: American Association of Blood Banks, 1993, p 66.
70. Ward JW, Bush TJ, Perkins HA, et al. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease [see comments]. N Engl J Med 1989;321:947-952.
71. Busch MP, Eble BE, Khayam BH, et al. Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. N Engl J Med 1991;325:1-5.
72. Donahue JG, Munoz A, Ness PM, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327: 369-373.
73. Nelson KE, Donahue JG, Munoz A, et al. Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections. Ann Intern Med 1992;117:554-559.
74. Aach RD, Szmuness W, Mosley JW, et al. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: The transfusion-transmitted viruses study. N Engl J Med 1981;304:989-994.
75. Alter HJ, Purcell RH, Holland PV, et al. Donor transaminase and recipient hepatitis. Impact on blood transfusion services. JAMA 1981;246:630-634.
76. Cessant YE, Kirsch S, Ismay SL. Post-transfusion hepatitis in Australia. Report of the Australian Red Cross study. Lancet 1982;1: 208-213.
77. Dienstag JL. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 1983;85:439-462.
78. Cooper ES, Walker RH, Schmidt PJ, Polesky HF. The 1990 Comprehensive Blood Bank Surveys of the College of American Pathologists. Arch Pathol Lab Med 1993;117:125-128.
79. Surgenor DM, Wallace EL, Churchill WH, et al. Red cell transfusions in coronary artery bypass surgery (DRGs 106 and 107). Transfusion 1992;32:458-464.
80. College of American Pathologists. Comprehensive Transfusion Medicine Survey. Northfield, IL: The Interlaboratory Comparison Program. College of American Pathologists, 1992.
81. Consensus Conference. Platelet transfusion therapy. JAMA 1987;257:1777-1780.
82. Goodnough LT. Blood conservation and blood transfusion practices: Flip sides of the same coin [Editorial]. Ann Thorac Surg 1993;56:3-4.